Clinafloxacin in Serious Infections Caused by Multiply Resistant Pathogens

被引：0

作者：

Kenneth J. Tack

Irene Eiseman

Marcus Zervos

机构：

[1] Parke-Davis Pharmaceutical Research,

[2] William Beaumont Hospital,undefined

来源：

Drugs | 1999年 / 58卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：260 / 262

页数：2

共 50 条

[1] Clinafloxacin in serious infections caused by multiply resistant pathogens
Tack, KJ
Eiseman, I
Zervos, M
[J]. DRUGS, 1999, 58 (Suppl 2) : 260 - 262
[2] Serious infections caused by multiply-resistant Enterococcus faecium
Wade, JJ
Rolando, N
Williams, R
Casewell, MW
[J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (03): : 241 - 243
[3] Future Management of Serious Infections with QuinolonesPlace of Clinafloxacin
Richard Wise
[J]. Clinical Drug Investigation, 1998, 15 : 39 - 46
[4] Introduction:: infections caused by emerging resistant pathogens
Bouza, E
Muñoz, P
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 : IV - IV
[5] Future management of serious infections with quinolones - Place of clinafloxacin
Wise, R
[J]. CLINICAL DRUG INVESTIGATION, 1998, 15 (Suppl 1) : 39 - 46
[6] MULTIPLY-RESISTANT PNEUMOCOCCUS - THERAPEUTIC PROBLEMS IN THE MANAGEMENT OF SERIOUS INFECTIONS
LISTER, PD
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 : S18 - S25
[7] Epidemiology of infections caused by polymyxin-resistant pathogens
Giamarellou, Helen
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2016, 48 (06) : 614 - 621
[8] Distribution of multiply resistant pathogens
Witte, W.
[J]. TRAUMA UND BERUFSKRANKHEIT, 2008, 10 : 125 - 132
[9] Clinafloxacin in the treatment of hospitalised patients with serious infections - Current status
Ramirez, JA
[J]. CLINICAL DRUG INVESTIGATION, 1998, 15 (Suppl 1) : 35 - 38
[10] OPEN STUDY OF CEFTAZIDIME IN SERIOUS INFECTIONS DUE TO MULTIPLY-RESISTANT BACTERIA
PECHERE, JC
DELISLE, R
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 181 - 188

← 1 2 3 4 5 →